UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of April 2021

 


 

Commission File Number: 001- 39167

 


 

Molecular Data Inc.

 

11/F, Building 15, 2177 Shenkun Road

Minhang District, Shanghai 201106

People’s Republic of China
(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F     x              Form 40-F      o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

 

 

 


 

EXHIBIT INDEX

 

Exhibit No.

 

Description

99.1*

 

Molecular Data has raised up to USD 7.5 million from an accredited investor

 


*      Exhibit 99.1 is furnished herewith solely for the purpose of meeting the requirements under Nasdaq Stock Market Rule 5250(c)(2) in connection with submission of an interim balance sheet and income statement as of the end of its second quarter.

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Molecular Data Inc.

 

 

 

By

:

/s/ Steven Foo

 

Name

:

Steven Foo

 

Title

:

Chief Financial Officer

 

Date: April 9, 2021

 

3


Molecular Data (NASDAQ:MKD)
Historical Stock Chart
From Oct 2021 to Nov 2021 Click Here for more Molecular Data Charts.
Molecular Data (NASDAQ:MKD)
Historical Stock Chart
From Nov 2020 to Nov 2021 Click Here for more Molecular Data Charts.